26
1 The Opioid Overdose Epidemic Epidemiology and Trends Christopher M. Jones, PharmD, MPH CDR, US Public Health Service Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention

The Opioid Overdose Epidemic Epidemiology and Trends for Disease Control and Prevention . National Center for Injury Prevention and Control . ... Noah \(CDC/ONDIEH/NCIPC\)

  • Upload
    buinhan

  • View
    213

  • Download
    0

Embed Size (px)

Citation preview

1

The Opioid Overdose Epidemic Epidemiology and Trends Christopher M. Jones, PharmD, MPH

CDR, US Public Health Service Centers for Disease Control and Prevention

National Center for Injury Prevention and Control Division of Unintentional Injury Prevention

2

Patients with mental health or substance use disorders are at increased risk for nonmedical use and overdose from prescription opioids…appropriate screening, identification, and clinical management by health care providers are essential parts of both behavioral health and chronic pain management and overdose prevention.

Thomas R. Frieden, MD, MPH Director, Centers for Disease Control and Prevention

February 20, 2013

3

Trends and Epidemiology

Nonmedical use Relationship between opioids and heroin Emergency department visits Dependence and abuse Overdose deaths Economic costs and additional public health

consequences

4

TRENDS IN USE

5

Past year nonmedical use of opioid analgesics and heroin have increased in the US

SAMHSA NSDUH 2012

404 669

10,992

12,489

0

2,000

4,000

6,000

8,000

10,000

12,000

14,000

2002 2012

Num

ber o

f use

rs a

mon

g pe

rson

s ≥ 1

2 ye

ars o

ld

(num

bers

in th

ousa

nds)

Year

Heroin

Opioid analgesics

6

Chronic nonmedical use of opioid analgesics has increased more than less frequent use

Jones CM. Frequency of prescription pain releiver nonmedical use, 2002-2003 and 2009-2010. Arch Intern Med. 2012 Sep 10;172(16):1265-7;

0

5

10

15

20

25

30

35

1-29 Days Past YearNonmedical Use

30-99 Days Past YearNonmedical Use

100-199 Days Past YearNonmedical Use

200-365 Days Past YearNonmedical Use

Rate

per

1,0

00 p

opul

atio

n ≥

12 y

ears

old

Frequency of Past Year Nonmedical Use

2002-2003

2009-201075%

Increase

7

Increase in heroin use has occurred among people who were past year nonmedical users

of opioid analgesics

Jones, C.M., Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers – United States, 2002–2004 and 2008–2010. Drug Alcohol Depend. (2013), http://dx.doi.org/10.1016/j.drugalcdep.2013.01.007

379

176

58 46

99

588

171

115 100

202

0

100

200

300

400

500

600

700

Overall Past YearHeroin Use

No Past Year NMUOpioids

1-29 Days PastYear NMU Opioids

30-99 Days PastYear NMU Opioids

100-365 Days PastYear NMU Opioids

Num

ber o

f pas

t yea

r use

rs a

mon

g pe

rson

s ≥1

2 ye

ars o

ld (n

umbe

rs in

thou

sand

s)

2002-2004

2008-2010

8

Frequent nonmedical users of opioids more likely to engage in risky use behaviors, US, 2008-2010.

Characteristic

1-29 Days of PYNMU of Opioid Pain Relievers

30-99 Days of PYNMU of Opioid Pain Relievers

100-365 Days of PYNMU of Opioid Pain Relievers

aOR (95% CI) aOR (95% CI) aOR (95% CI)

Past Year Heroin Use referent 2.8 (1.7-4.5) 6.4 (3.7-11.1)

Ever Inject Heroin referent 1.6 (0.9-2.9) 4.3 (2.5-7.3)

Ever Inject Opioid Pain Relievers

referent 3.8 (1.9-7.8) 13.3 (7.7-23.0)

Past Year Heroin Abuse or Dependence

referent 3.2 (1.7-6.1) 7.8 (4.7-12.8)

Past Year Opioid Pain Reliever Abuse or Dependence

referent 2.9 (2.3-3.8) 8.9 (7.1-11.3)

Heroin Fairly or Very Easy to Obtain

referent 1.4 (1.1-1.7) 2.1 (1.8-2.6)

Abbreviations: PYNMU, past year nonmedical use; aOR, adjusted Odds Ratio; 95% CI, 95% Confidence Interval

1Odds ratio adjusted for sex, age, race/ethnicity, total family income, and county type

Jones, C.M., Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers – United States, 2002–2004 and 2008–2010. Drug Alcohol Depend. (2013), http://dx.doi.org/10.1016/j.drugalcdep.2013.01.007

9

18-25 year olds have highest rates of chronic nonmedical use of opioid analgesics and

heroin use

Jones CM. Frequency of prescription pain releiver nonmedical use, 2002-2003 and 2009-2010. Arch Intern Med. 2012 Sep 10;172(16):1265-7; SAMHSA NSDUH Public Use File 2011

0

1

2

3

4

5

6

7

8

12-17 18-25 26-34 35-49 50+

Rate

per

1,0

00 p

opul

atio

n

Age Group

Past year chronic nonmedical use Past year heroin use

10

EMERGENCY DEPARTMENT VISITS

11

Increasing number of ED visits due to nonmedical use of opioid analgesics and use

of heroin

SAMHSA DAWN ED Public Use Files 2004-2011

0

50,000

100,000

150,000

200,000

250,000

300,000

350,000

400,000

2004 2005 2006 2007 2008 2009 2010 2011

Num

ber o

f ED

visi

ts

Year

Opioid analgesics

Heroin

12

18-34 year olds have highest rates of ED visits due to nonmedical use of opioid analgesics

and heroin use

SAMHSA DAWN ED Public Use Files 2011

0

50

100

150

200

250

12-17 18-24 25-34 35-44 45-54 55-64 65+

Rate

per

100

,000

pop

ulat

ion

Age Group

Opioid analgesics Heroin

13

DEPENDENCE AND ABUSE

14

Significant increases in number of people classified with and receiving treatment for dependence or abuse

of opioid analgesics and heroin

SAMHSA NSDUH 2012

1,509

214

360 277

2,056

467

973

450

0

500

1,000

1,500

2,000

2,500

Abuse or dependence -opioid analgesics

Abuse or dependence -heroin

Treatment - opioidanalgesics

Treatment - heroin

Num

ber o

f per

sons

in th

e U

S 12

yea

rs a

nd o

lder

(in

thou

sand

s)

2002

2012

15

18-25 year olds have highest rate of dependence or abuse of opioid analgesics and

heroin

SAMHSA NSDUH Public Use Files 2008-2011

0

2

4

6

8

10

12

14

16

18

20

12-17 18-25 26-34 35-49 50-64 65+

Rate

per

1,0

00 p

opul

atio

n

Age Group

Opioid Analgesic Heroin

16

OVERDOSE DEATHS

17

Drug overdose death rates continue to increase; unprecedented death rate

NCHS Data Brief, December, 2011, Updated with 2009 and 2010 mortality data

0

5

10

15

20

25

1980 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010

Dea

ths

per 1

00,0

00 p

opul

atio

n

Year

Motor Vehicle Traffic Drug Poisoning (Overdose)

18

11 years of increases in opioid analgesic overdose deaths; heroin deaths increasing in

recent years

CDC NCHS/NVSS Mutliple Cause of Death File 1999-2010

0

2,000

4,000

6,000

8,000

10,000

12,000

14,000

16,000

18,000

1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010

Num

ber o

f dea

ths

Year

Opioid analgesics

Heroin

19

Opioid analgesics #1 drug involved in overdose deaths; heroin #5

Jones CM et al Pharmaceutical overdose deaths, United States, 2010. JAMA 2013 and CDC/NCHS NVSS MCOD 2010

0

2,000

4,000

6,000

8,000

10,000

12,000

14,000

16,000

18,000

Ddea

ths

Drug Class

20

Opioid analgesic death rates highest in 45-54; heroin highest in 25-34

CDC NCHS/NVSS Mutliple Cause of Death File 2010

0

2

4

6

8

10

12

12-17 18-24 25-34 35-44 45-54 55-64 65+

Deat

hs p

er 1

00,0

00 p

opul

atio

n

Age Group

Opioid analgesics Heroin

Additional risk factors

Demographics Men Whites American Indians/Alaska Natives

Socioeconomics and Geography Medicaid Rural vs urban

ECONOMIC COSTS AND ADDITIONAL PUBLIC HEALTH

CONSEQUENCES

23

Economic costs and additional public health consequences $72.5 Billion in healthcare costs

People who abuse opioids generate, on average, annual direct health care costs 8.7 times higher than nonabusers

Increase in hepatitis C Other infectious disease

complications Neonatal abstinence syndrome

Coalition Against Insurance Fraud. Prescription for peril: how insurance fraud finances theft and abuse of addictive prescription drugs. Washington, DC: Coalition Against Insurance Fraud; 2007 White AG, Birnbaum, HG, Mareva MN, et al. Direct Costs of Opioid Abuse in an Insured Population in the United States. J Manag Care Pharm. 11(6):469-479. 2005 Klevens, R.M., Hu, D.J., Jiles, R., Holmberg, S.D., 2012. Evolving epidemiology of hepatitis C virus in the United States. Clin. Infect. Dis. 55

(Suppl.), S3–S9. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012;9;307(18):1934-1940.

24

Of 75 patients who underwent AAROD at a NYC clinic during January–September 2012, 2 died and 5 others experienced serious adverse events requiring hospitalization.

To reduce morbidity and mortality associated with opioid dependence, evidence-based approaches (e.g., medication-assisted treatment) should be used for its management.

http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6238a1.htm?s_cid=mm6238a1_e

Conclusions

Abuse of opioids has increased over the last decade Overdose deaths from these drugs exact significant

health, economic, and social consequences People with substance use disorders are at high risk

for overdose death This is a complex problem with multiple drivers

which requires a multi-pronged response strategy Expanding access to medication assisted treatment

is an essential component of this strategy

26

Thank You

Christopher M. Jones - - [email protected]

The findings and conclusions in this report are those of the author and do not necessarily represent the views of the Centers for Disease Control and Prevention.